Lobe Sciences Ltd.

Recent News

  • Lobe Sciences Announces Roadmap for Remainder of 2022 and Early 2023

    Vancouver, British Columbia--(Newsfile Corp. - June 14, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBED) ("Lobe" or the "Company"), a Canadian Biopharmaceutical Company committed to discovering and developing psychedelic inspired medicines for the improvement of neurologic, brain and mental health disorders is reporting its roadmap for the remainder of 2022 and into 2023.Philip Young CEO and Director stated, "I am happy to report that we have made significant progress since our last update in Q3 last year. The next...

    2022-06-14 8:44 AM EDT
  • Lobe Sciences Ltd Announces Change in Record Date of Share Consolidation

    Vancouver, British Columbia--(Newsfile Corp. - June 9, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company") announces that further to the Company's June 6, 2022, news release, the record date for the six for one consolidation has been adjusted to June 10, 2022.The Canadian Securities Exchange has published a bulletin confirming that trading will remain halted June 9, 2022, and resume trading on a consolidated basis on Friday, June 10.About Lobe Sciences Ltd.Lobe Sciences is a...

    2022-06-09 10:28 AM EDT
  • Lobe Sciences Announces Share Consolidation

    Vancouver, British Columbia--(Newsfile Corp. - June 6, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company") announces that its board of directors has authorized the implementation of a consolidation (the "Consolidation") of the Company's common shares (the "Shares") on the basis of one (1) post-Consolidation Share for every six (6) pre-Consolidation Shares, which will become effective on June 9, 2022 (the "Effective Date"). Neither the Company's name, nor its trading symbols, will change as a result...

    2022-06-06 4:05 PM EDT
  • Lobe Sciences Ltd. to Participate in the Lytham Partners Spring 2022 Investor Conference

    Vancouver, British Columbia--(Newsfile Corp. - March 30, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company") announced today that it will be participating in the Lytham Partners Spring 2022 Investor Conference taking place virtually on April 4-7, 2022.The Company's webcast presentation will be available for viewing at 11:00am ET on Monday, April 4, 2022, on the Company's website or at https://wsw.com/webcast/lytham4/lobef/2174264. The webcast will also be archived and available for replay.Management will be participating in virtual...

    2022-03-30 8:09 AM EDT
  • Lobe Sciences Ltd. to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest on March 28th - 30th from 9:00 A.M. - 5:00 P.M. EDT

    Vancouver, British Columbia--(Newsfile Corp. - March 23, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company") announced today that Philip Young, CEO, has been invited to present at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT.Sign up here to access the presentationDuring this virtual conference, investors will hear from executives from a wide range of sectors including...

    2022-03-23 9:51 AM EDT
  • Lobe Sciences to Present at MONEYSHOW VIRTUAL EXPO March, 23 2022

    Vancouver, British Columbia--(Newsfile Corp. - March 22, 2022) -  Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company") today announced that Philip Young, CEO and Director, will present at the MONEYSHOW VIRTUAL EXPO, March 23rd at 11:30AM EST.The presentation will be available on demand through the MONEYSHOW VIRTUAL EXPO Meeting site at this link, Lobe Sciences Is Developing and Delivering Solutions to Improve the Human Condition.Registration for the event is accessible via the following link Sign up free.The...

    2022-03-22 12:29 PM EDT
  • Lobe Sciences Ltd. Strengthens Its Balance Sheet

    Vancouver, British Columbia--(Newsfile Corp. - March 7, 2022) - Lobe Sciences Ltd. (the "Acquiror") announces, pursuant to the early warning requirements of Canadian securities legislation, that on February 25, 2022, February 28, 2022, March 2, 2022 and March 3, 2022, it sold at total of 25,254,000 common shares in the capital of Ionic Brands Corp. (the "Issuer" and the common shares of the Issuer referred to as the "Common Shares"), which were originally issued to the Acquiror on February...

    2022-03-07 9:06 AM EST
  • Lobe Sciences Ltd. Strengthens Its Balance Sheet

    Vancouver, British Columbia--(Newsfile Corp. - February 24, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) (the "Acquiror") announces, pursuant to the early warning requirements of Canadian securities legislation, that on February 22, 2022 and February 23, 2022, it sold a total of 4,500,000 common shares in the capital of Ionic Brands Corp. (the "Issuer" and the common shares of the Issuer referred to as the "Common Shares"), which were originally issued to the Acquiror on February 3, 2022 as...

    2022-02-24 9:39 AM EST